Love Our Children USA Corporation – Trademark Portfolio
Entity Type: 03
Love Our Children USA Corporation holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include STOMP OUT BULLYING. The owner is based in New York, NY.
220 East 57th Street
New York, NY 100222820
Showing of trademarks Trademarks
Trademark Classifications
Love Our Children USA Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Love Our Children USA Corporation have?
Love Our Children USA Corporation has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.
What trademark classes does Love Our Children USA Corporation file in?
Love Our Children USA Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Love Our Children USA Corporation's most well-known trademarks?
Love Our Children USA Corporation's registered trademark portfolio includes well-known marks such as STOMP OUT BULLYING. These are among 1 currently registered trademark in the portfolio.
What is Love Our Children USA Corporation's trademark registration success rate?
Love Our Children USA Corporation has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.